Filing Details
- Accession Number:
- 0001367644-20-000035
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-08 20:22:14
- Reporting Period:
- 2020-04-06
- Accepted Time:
- 2020-04-08 20:22:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1514588 | Adam Havey | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Evp, Business Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-04-06 | 4,242 | $60.00 | 37,986 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-04-06 | 3,730 | $60.00 | 34,256 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.